In hepatocellular carcinoma, SIRT3 reduction promotes cyclin E2 lactylation, enhancing the proliferation and invasion of hepatocellular carcinoma cells (Jin et al., 2023). The gene discussed is SIRT3; the disease is hepatocellular carcinoma.